person · Reporting owner

Kaseta Michael

Disclosed activity across 4 companies

Tapewire entity: 30464
SEC CIK: 0001724346

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Aralez Pharmaceuticals Inc.ARLZ · Entity 165961	Chief Financial Officer	March 15, 2018	March 19, 2018
HERON THERAPEUTICS, INC. /DE/HRTX · Entity 7133	Director	January 30, 2026	February 03, 2026
Liquidia CorpLQDA · Entity 1860	CFO and COO	October 09, 2026	October 14, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Aralez Pharmaceuticals Inc.

Report date March 15, 2018 · Filed March 19, 2018

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Shares, without par valueSEC Table I · non-derivative	Direct	15,000	Reported balance After 2018-03-15 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2018-03-15 · Grant · Acquired 12,500 · Balance 15,000 F1: Restricted Stock Units granted pursuant to the Aralez Pharmaceuticals Inc. 2016 Amended and Restated Long-Term Incentive Plan, which vest 33.3% annually over three years commencing upon the first anniversary of the date of grant, subject to continued employment or service to the Company. F2: Includes 833 shares of Common Stock and 14,167 Restricted Stock Units.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.75 · Expires 2028-03-15	Direct	25,000	Reported balance After 2018-03-15 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2018-03-15 · Grant · Acquired 25,000 · Balance 25,000 F3: The option vests as to 25% of the shares on March 15, 2019, and the remainder vests in substantially equal monthly installments over the 36 months immediately following such date, subject to continued employment or service to the Company.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted Stock Units granted pursuant to the Aralez Pharmaceuticals Inc. 2016 Amended and Restated Long-Term Incentive Plan, which vest 33.3% annually over three years commencing upon the first anniversary of the date of grant, subject to continued employment or service to the Company.

F2: Includes 833 shares of Common Stock and 14,167 Restricted Stock Units.

F3: The option vests as to 25% of the shares on March 15, 2019, and the remainder vests in substantially equal monthly installments over the 36 months immediately following such date, subject to continued employment or service to the Company.

HERON THERAPEUTICS, INC. /DE/

Report date January 30, 2026 · Filed February 03, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	53,960	Reported balance After 2026-01-30 transaction · row 1 1 source row Row 1 · 2026-01-30 · Grant · Acquired 53,960 · Balance 53,960 F1: The shares were granted as restricted stock units which vest in full on January 30, 2027. Each restricted stock unit represents a contigent right to receive one share of common stock.

Filing footnotes · ownership attribution and instrument terms

F1: The shares were granted as restricted stock units which vest in full on January 30, 2027. Each restricted stock unit represents a contigent right to receive one share of common stock.

Liquidia Corp

Report date October 09, 2026 · Filed October 14, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	340,148	Last balance in matching sequence After 2026-10-12 transaction · row 3 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 3 source rows Row 1 · 2026-10-09 · Exercise / conversion · Acquired 5,828 · Balance 352,037 F2: On January 11, 2024, the Reporting Person was granted 93,250 PSUs with 25% of the PSUs vesting on January 11, 2025 and the remaining PSUs vesting ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 64,110 have vested as of the date of this Form 4. F1: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3: Includes (i) 7,792 unvested restricted stock units ("RSUs") of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 29,140 unvested RSUs and 15,625 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 63,448 unvested RSUs of the 112,797 RSUs granted to the Reporting Person on January 11, 2025, (iv) 59,320 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 3,054 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan ("ESPP"). Row 2 · 2026-10-09 · Exercise / conversion · Acquired 7,049 · Balance 359,086 F4: On January 11, 2025, the Reporting Person was granted 112,797 PSUs with 25% of the PSUs vesting on January 11, 2026 and the remaining PSUs vesting ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 49,349 have vested as of the date of this Form 4. F1: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3: Includes (i) 7,792 unvested restricted stock units ("RSUs") of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 29,140 unvested RSUs and 15,625 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 63,448 unvested RSUs of the 112,797 RSUs granted to the Reporting Person on January 11, 2025, (iv) 59,320 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 3,054 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan ("ESPP"). Row 3 · 2026-10-12 · Sale · Disposed 18,938 · Balance 340,148 F5: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F6: These shares of common stock were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024, January 15, 2024 and January 11, 2025. F3: Includes (i) 7,792 unvested restricted stock units ("RSUs") of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 29,140 unvested RSUs and 15,625 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 63,448 unvested RSUs of the 112,797 RSUs granted to the Reporting Person on January 11, 2025, (iv) 59,320 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 3,054 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan ("ESPP").
Performance Stock UnitsSEC Table II · derivative / convertible security	Direct	29,140	Reported balance After 2026-10-09 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2026-10-09 · Exercise / conversion · Disposed 5,828 · Balance 29,140 F1: Performance stock units ("PSUs") convert into common stock on a one-for-one basis.
Performance Stock UnitsSEC Table II · derivative / convertible security	Direct	63,448	Reported balance After 2026-10-09 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2026-10-09 · Exercise / conversion · Disposed 7,049 · Balance 63,448 F1: Performance stock units ("PSUs") convert into common stock on a one-for-one basis.

Filing footnotes · ownership attribution and instrument terms

F1: Performance stock units ("PSUs") convert into common stock on a one-for-one basis.

F2: On January 11, 2024, the Reporting Person was granted 93,250 PSUs with 25% of the PSUs vesting on January 11, 2025 and the remaining PSUs vesting ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 64,110 have vested as of the date of this Form 4.

F3: Includes (i) 7,792 unvested restricted stock units ("RSUs") of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 29,140 unvested RSUs and 15,625 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 63,448 unvested RSUs of the 112,797 RSUs granted to the Reporting Person on January 11, 2025, (iv) 59,320 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 3,054 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan ("ESPP").

F4: On January 11, 2025, the Reporting Person was granted 112,797 PSUs with 25% of the PSUs vesting on January 11, 2026 and the remaining PSUs vesting ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 49,349 have vested as of the date of this Form 4.

F5: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023.

F6: These shares of common stock were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024, January 15, 2024 and January 11, 2025.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

ALIMERA SCIENCES INC

Report date September 16, 2024 · Filed September 18, 2024

Section 16 reporting ended · disclosed 2024-09-18. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.99 · Expires 2033-10-01	Direct	0	Reported balance After 2024-09-16 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2024-09-16 · Disposition to issuer · Disposed 50,000 · Balance 0 F1: Pursuant to the terms of the Agreement and Plan of Merger, dated as of June 21, 2024 (the "Merger Agreement"), by and among the Issuer, ANI Pharmaceuticals, Inc., a Delaware corporation ("Parent") and ANIP Merger Sub INC., a Delaware corporation and a wholly owned indirect subsidiary of Parent, as of the effective time of the merger (the "Effective Time"), at the Effective Time, each stock option granted by the Issuer to purchase shares (each, an "Option") that was outstanding and unvested immediately prior to the Effective Time vested in full, and each Option that was outstanding and unexercised which had a per share exercise price that was less than ) $5.50 in cash, without interest (such amount, the "Closing Cash Consideration") was converted into the right to receive the sum of an amount in cash (without interest and subject to deduction for any required withholding as contemplated in the Merger Agreement) equal to: F2: (A) the excess, if any, of the Closing Cash Consideration over the exercise price per share of such Option; multiplied by the number of shares underlying such Option and (B) one contingent value right ("CVR") representing the right to receive contingent cash payments subject to the achievement of certain milestones and the terms and conditions set forth in a contingent value rights agreement entered into between Parent and a rights agent.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.85 · Expires 2033-03-25	Direct	0	Reported balance After 2024-09-16 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2024-09-16 · Disposition to issuer · Disposed 1,825 · Balance 0 F1: Pursuant to the terms of the Agreement and Plan of Merger, dated as of June 21, 2024 (the "Merger Agreement"), by and among the Issuer, ANI Pharmaceuticals, Inc., a Delaware corporation ("Parent") and ANIP Merger Sub INC., a Delaware corporation and a wholly owned indirect subsidiary of Parent, as of the effective time of the merger (the "Effective Time"), at the Effective Time, each stock option granted by the Issuer to purchase shares (each, an "Option") that was outstanding and unvested immediately prior to the Effective Time vested in full, and each Option that was outstanding and unexercised which had a per share exercise price that was less than ) $5.50 in cash, without interest (such amount, the "Closing Cash Consideration") was converted into the right to receive the sum of an amount in cash (without interest and subject to deduction for any required withholding as contemplated in the Merger Agreement) equal to: F2: (A) the excess, if any, of the Closing Cash Consideration over the exercise price per share of such Option; multiplied by the number of shares underlying such Option and (B) one contingent value right ("CVR") representing the right to receive contingent cash payments subject to the achievement of certain milestones and the terms and conditions set forth in a contingent value rights agreement entered into between Parent and a rights agent.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the terms of the Agreement and Plan of Merger, dated as of June 21, 2024 (the "Merger Agreement"), by and among the Issuer, ANI Pharmaceuticals, Inc., a Delaware corporation ("Parent") and ANIP Merger Sub INC., a Delaware corporation and a wholly owned indirect subsidiary of Parent, as of the effective time of the merger (the "Effective Time"), at the Effective Time, each stock option granted by the Issuer to purchase shares (each, an "Option") that was outstanding and unvested immediately prior to the Effective Time vested in full, and each Option that was outstanding and unexercised which had a per share exercise price that was less than ) $5.50 in cash, without interest (such amount, the "Closing Cash Consideration") was converted into the right to receive the sum of an amount in cash (without interest and subject to deduction for any required withholding as contemplated in the Merger Agreement) equal to:

F2: (A) the excess, if any, of the Closing Cash Consideration over the exercise price per share of such Option; multiplied by the number of shares underlying such Option and (B) one contingent value right ("CVR") representing the right to receive contingent cash payments subject to the achievement of certain milestones and the terms and conditions set forth in a contingent value rights agreement entered into between Parent and a rights agent.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
November 28, 2025 Filed Dec 2, 2025 21:32 UTC	Liquidia Corp LQDA · Entity 1860	Exercise / conversionRestricted Stock Units · Derivative	2,343	$0.00	$0.00	Disclosure SEC source: 0001104659-25-117739 · tm2532579-4_4seq1.xml · derivative · entry 3 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,344 Underlying: Common Stock · 2,343 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis F1 · derivative.exercise_date: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis F1 · derivative.expiration_date: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis Read SEC document
November 28, 2025 Filed Dec 2, 2025 21:32 UTC	Liquidia Corp LQDA · Entity 1860	Exercise / conversionCommon Stock	2,343	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-25-117739 · tm2532579-4_4seq1.xml · nonDerivative · entry 1 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 354,989 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 16, 2022, the Reporting Person was granted 37,500 RSUs with 25% vesting on February 28, 2023 and the remaining RSUs vesting ratably on a quarterly basis over three years thereafter. Of those RSUs, a total of 35,156 have vested as of the date of this Form 4. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis F3 · balance_after: Includes (i) 38,958 unvested RSUs of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 52,453 unvested RSUs and 28,125 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 112,797 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4 and (iv) 11,257 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
October 13, 2025 Filed Oct 15, 2025 20:34 UTC	Liquidia Corp LQDA · Entity 1860	SaleCommon Stock	11,630	$23.41	$272,258.30	Disclosure SEC source: 0001104659-25-099752 · tm2528808-7_4seq1.xml · nonDerivative · entry 2 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 352,646 F4 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F5 · shares: These shares of common stock were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024 and January 15, 2024. F3 · balance_after: Includes (i) 38,958 unvested restricted stock units ("RSUs") of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 52,453 unvested RSUs and 28,125 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 112,797 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4 and (iv) 11,257 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
October 10, 2025 Filed Oct 15, 2025 20:34 UTC	Liquidia Corp LQDA · Entity 1860	Exercise / conversionPerformance Stock Unit · Derivative	5,828	$0.00	$0.00	Disclosure SEC source: 0001104659-25-099752 · tm2528808-7_4seq1.xml · derivative · entry 3 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,453 Underlying: Common Stock · 5,828 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis F1 · derivative.exercise_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis F1 · derivative.expiration_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis Read SEC document
October 10, 2025 Filed Oct 15, 2025 20:34 UTC	Liquidia Corp LQDA · Entity 1860	Exercise / conversionCommon Stock	5,828	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-25-099752 · tm2528808-7_4seq1.xml · nonDerivative · entry 1 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 364,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 11, 2024, the Reporting Person was granted 93,250 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 40,797 have vested as of the date of this Form 4. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis F3 · balance_after: Includes (i) 38,958 unvested restricted stock units ("RSUs") of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 52,453 unvested RSUs and 28,125 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 112,797 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4 and (iv) 11,257 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
September 02, 2025 Filed Sep 3, 2025 20:31 UTC	Liquidia Corp LQDA · Entity 1860	SaleCommon Stock	1,148	$29.05	$33,349.40	Disclosure SEC source: 0001104659-25-087062 · tm2525145-2_4seq1.xml · nonDerivative · entry 2 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 358,448 F4 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F5 · shares: These shares of common stock were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on January 16, 2022. F2 · price: On January 16, 2022, the Reporting Person was granted 37,500 RSUs with 25% vesting on February 28, 2023 and the remaining RSUs vesting ratably on a quarterly basis over three years thereafter. Of those RSUs, a total of 32,813 have vested as of the date of this Form 4. F3 · balance_after: Includes (i) 46,750 unvested RSUs of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 58,281 unvested RSUs and 31,250 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 112,797 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4 and (iv) 11,257 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
August 31, 2025 Filed Sep 3, 2025 20:31 UTC	Liquidia Corp LQDA · Entity 1860	Exercise / conversionRestricted Stock Unit · Derivative	2,344	$0.00	$0.00	Disclosure SEC source: 0001104659-25-087062 · tm2525145-2_4seq1.xml · derivative · entry 3 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,687 Underlying: Common Stock · 2,344 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis F1 · derivative.exercise_date: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis F1 · derivative.expiration_date: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis Read SEC document
August 29, 2025 Filed Sep 3, 2025 20:31 UTC	Liquidia Corp LQDA · Entity 1860	Exercise / conversionCommon Stock	2,344	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-25-087062 · tm2525145-2_4seq1.xml · nonDerivative · entry 1 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 359,596 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 16, 2022, the Reporting Person was granted 37,500 RSUs with 25% vesting on February 28, 2023 and the remaining RSUs vesting ratably on a quarterly basis over three years thereafter. Of those RSUs, a total of 32,813 have vested as of the date of this Form 4. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis F3 · balance_after: Includes (i) 46,750 unvested RSUs of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 58,281 unvested RSUs and 31,250 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 112,797 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4 and (iv) 11,257 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
August 15, 2025 Filed Aug 19, 2025 20:30 UTC	Liquidia Corp LQDA · Entity 1860	SaleCommon Stock	20,000	$26.18	$523,674.00	Disclosure SEC source: 0001104659-25-080283 · tm2523755-1_4seq1.xml · nonDerivative · entry 1 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 356,412 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 9, 2024. F2 · price: Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $25.80 to $26.50. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes (i) 46,750 unvested restricted stock units ("RSUs") of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 58,281 unvested RSUs and 31,250 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 112,797 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4 and (iv) 10,417 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
August 05, 2025 Filed Aug 7, 2025 20:30 UTC	Liquidia Corp LQDA · Entity 1860	SaleCommon Stock	30,000	$20.00	$600,132.00	Disclosure SEC source: 0001104659-25-075216 · tm2522794-1_4seq1.xml · nonDerivative · entry 1 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 376,412 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 9, 2024. F2 · price: Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $20.00 to $20.04. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes (i) 46,750 unvested restricted stock units ("RSUs") of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 58,281 unvested RSUs and 31,250 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 112,797 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4 and (iv) 10,417 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
July 14, 2025 Filed Jul 15, 2025 20:34 UTC	Liquidia Corp LQDA · Entity 1860	SaleCommon Stock	11,580	$14.28	$165,362.40	Disclosure SEC source: 0001104659-25-068120 · tm2520991-4_4seq1.xml · nonDerivative · entry 2 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 406,412 F4 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F5 · shares: These shares of common stock were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023 and January 11, 2024. F3 · balance_after: Includes (i) 46,750 unvested restricted stock units ("RSUs") of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 58,281 unvested RSUs and 31,250 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 112,797 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4 and (iv) 10,417 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
July 11, 2025 Filed Jul 15, 2025 20:34 UTC	Liquidia Corp LQDA · Entity 1860	Exercise / conversionPerformance Stock Units · Derivative	5,828	$0.00	$0.00	Disclosure SEC source: 0001104659-25-068120 · tm2520991-4_4seq1.xml · derivative · entry 3 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,281 Underlying: Common Stock · 5,828 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. Read SEC document
July 11, 2025 Filed Jul 15, 2025 20:34 UTC	Liquidia Corp LQDA · Entity 1860	Exercise / conversionCommon Stock	5,828	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-25-068120 · tm2520991-4_4seq1.xml · nonDerivative · entry 1 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 417,992 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 11, 2024, the Reporting Person was granted 93,250 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 34,969 have vested as of the date of this Form 4. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 46,750 unvested restricted stock units ("RSUs") of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 58,281 unvested RSUs and 31,250 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 112,797 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4 and (iv) 10,417 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
June 04, 2025 Filed Jun 5, 2025 20:18 UTC	Liquidia Corp LQDA · Entity 1860	SaleCommon Stock	14,777	$16.97	$250,765.69	Disclosure SEC source: 0001104659-25-056848 · tm2517227-3_4seq1.xml · nonDerivative · entry 2 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 412,164 F4 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F5 · shares: These shares of common stock were sold to cover taxes associated with the settlement of PSUs that were initially granted to the Reporting Person on January 11, 2024. F3 · balance_after: Includes (i) 54,542 unvested restricted stock units ("RSUs") of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 64,109 unvested RSUs and 34,375 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 112,797 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4 and (iv) 10,417 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
June 03, 2025 Filed Jun 5, 2025 20:18 UTC	Liquidia Corp LQDA · Entity 1860	Exercise / conversionPerformance Stock Units · Derivative	29,141	$0.00	$0.00	Disclosure SEC source: 0001104659-25-056848 · tm2517227-3_4seq1.xml · derivative · entry 3 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,109 Underlying: Common Stock · 29,141 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. Read SEC document
June 03, 2025 Filed Jun 5, 2025 20:18 UTC	Liquidia Corp LQDA · Entity 1860	Exercise / conversionCommon Stock	29,141	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-25-056848 · tm2517227-3_4seq1.xml · nonDerivative · entry 1 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 426,941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 11, 2024, the Reporting Person was granted 93,250 PSUs which vest upon the later of (A) the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter and (B) the first commercial sale of YUTREPIA by the Issuer. Of those PSUs, a total of 29,141 have vested through June 3, 2025. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 54,542 unvested restricted stock units ("RSUs") of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 64,109 unvested RSUs and 34,375 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 112,797 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4 and (iv) 10,417 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
June 02, 2025 Filed Jun 3, 2025 20:45 UTC	Liquidia Corp LQDA · Entity 1860	SaleCommon Stock	859	$16.74	$14,379.66	Disclosure SEC source: 0001104659-25-056000 · tm2517010-2_4seq1.xml · nonDerivative · entry 2 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 397,800 F4 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F5 · shares: These shares of common stock were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on January 16, 2022. F3 · balance_after: Includes (i) 54,542 unvested RSUs of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 64,109 unvested RSUs and 34,375 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 112,797 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4 and (iv) 10,417 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
May 30, 2025 Filed Jun 3, 2025 20:45 UTC	Liquidia Corp LQDA · Entity 1860	Exercise / conversionRestricted Stock Unit · Derivative	2,344	$0.00	$0.00	Disclosure SEC source: 0001104659-25-056000 · tm2517010-2_4seq1.xml · derivative · entry 3 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,031 Underlying: Common Stock · 2,344 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. Read SEC document
May 30, 2025 Filed Jun 3, 2025 20:45 UTC	Liquidia Corp LQDA · Entity 1860	Exercise / conversionCommon Stock	2,344	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-25-056000 · tm2517010-2_4seq1.xml · nonDerivative · entry 1 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 398,659 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 16, 2022, the Reporting Person was granted 37,500 RSUs with 25% vesting on February 28, 2023 and the remaining RSUs vesting ratably on a quarterly basis over three years thereafter. Of those RSUs, a total of 30,469 have vested through May 30, 2025. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 54,542 unvested RSUs of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 64,109 unvested RSUs and 34,375 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 112,797 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4 and (iv) 10,417 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
April 14, 2025 Filed Apr 16, 2025 21:03 UTC	Liquidia Corp LQDA · Entity 1860	SaleCommon Stock	8,283	$13.57	$112,400.31	Disclosure SEC source: 0001104659-25-035544 · tm2512499-2_4seq1.xml · nonDerivative · entry 1 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 396,315 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F2 · shares: These shares of common stock were sold to cover taxes associated with the settlement of restricted stock units ("RSUs"). F3 · balance_after: Includes (i) 54,542 unvested RSUs of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 64,109 unvested RSUs and 34,375 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 112,797 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4 and (iv) 10,417 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
March 03, 2025 Filed Mar 4, 2025 21:31 UTC	Liquidia Corp LQDA · Entity 1860	SaleCommon Stock	874	$15.45	$13,503.30	Disclosure SEC source: 0001104659-25-020350 · tm258244-2_4seq1.xml · nonDerivative · entry 2 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 404,598 F4 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F5 · shares: These shares of common stock were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on January 16, 2022. F3 · balance_after: Includes (i) 62,333 unvested RSUs of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 69,937 unvested RSUs and 37,500 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 112,797 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4 and (iv) 10,417 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
February 28, 2025 Filed Mar 4, 2025 21:31 UTC	Liquidia Corp LQDA · Entity 1860	Exercise / conversionRestricted Stock Unit · Derivative	2,344	$0.00	$0.00	Disclosure SEC source: 0001104659-25-020350 · tm258244-2_4seq1.xml · derivative · entry 3 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,375 Underlying: Common Stock · 2,344 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. Read SEC document
February 28, 2025 Filed Mar 4, 2025 21:31 UTC	Liquidia Corp LQDA · Entity 1860	Exercise / conversionCommon Stock	2,344	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-25-020350 · tm258244-2_4seq1.xml · nonDerivative · entry 1 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 405,472 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 16, 2022, the Reporting Person was granted 37,500 RSUs with 25% vesting on February 28, 2023 and the remaining RSUs vesting ratably on a quarterly basis over three years thereafter. Of those RSUs, a total of 28,125 have vested through February 28, 2025. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 62,333 unvested RSUs of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 69,937 unvested RSUs and 37,500 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 112,797 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4 and (iv) 10,417 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
January 31, 2025 Filed Feb 4, 2025 22:40 UTC Amendment	HERON THERAPEUTICS, INC. /DE/ HRTX · Entity 7133	GrantStock Option (Right to Buy) · Derivative	35,900	$0.00 Strike: $1.70	$0.00	Disclosure SEC source: 0000950170-25-013789 · ownership.xml · derivative · entry 2 Kaseta Michael · CIK 0001724346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,900 Underlying: Common Stock · 35,900 shares Expires 2035-01-31 F2 · derivative.exercise_date: The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant. Read SEC document
January 31, 2025 Filed Feb 4, 2025 22:40 UTC Amendment	HERON THERAPEUTICS, INC. /DE/ HRTX · Entity 7133	GrantCommon Stock	17,950	$0.00	$0.00	Disclosure SEC source: 0000950170-25-013789 · ownership.xml · nonDerivative · entry 1 Kaseta Michael · CIK 0001724346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,829 F1 · shares: The shares were granted as restricted stock units which vest in full on January 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document
January 30, 2025 Filed Feb 3, 2025 16:58 UTC	HERON THERAPEUTICS, INC. /DE/ HRTX · Entity 7133	GrantStock Option (Right to Buy) · Derivative	35,900	$1.73 Strike: $1.73	$62,107.00	Disclosure SEC source: 0000950170-25-012119 · ownership.xml · derivative · entry 2 Kaseta Michael · CIK 0001724346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,900 Underlying: Common Stock · 35,900 shares Expires 2035-01-30 F2 · derivative.exercise_date: The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant. Read SEC document
January 30, 2025 Filed Feb 3, 2025 16:58 UTC	HERON THERAPEUTICS, INC. /DE/ HRTX · Entity 7133	GrantCommon Stock	17,950	$0.00	$0.00	Disclosure SEC source: 0000950170-25-012119 · ownership.xml · nonDerivative · entry 1 Kaseta Michael · CIK 0001724346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,829 F1 · shares: The shares were granted as restricted stock units which vest in full on January 30, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document
January 14, 2025 Filed Jan 14, 2025 21:37 UTC	Liquidia Corp LQDA · Entity 1860	SaleCommon Stock	23,370	$11.78	$275,298.60	Disclosure SEC source: 0001104659-25-003470 · tm253294-3_4seq1.xml · nonDerivative · entry 2 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 401,755 F4 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F5 · shares: These shares of common stock were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024 and January 15, 2024. F3 · balance_after: Includes (i) 62,333 unvested RSUs of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 69,937 unvested RSUs of the 93,250 RSUs granted to the Reporting Person on January 11, 2024, (iii) 37,500 unvested RSUs of the 50,000 RSUs granted to the Reporting Person on January 15, 2024 and (iv) 9,044 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
January 11, 2025 Filed Jan 14, 2025 21:37 UTC	Liquidia Corp LQDA · Entity 1860	GrantPerformance Stock Units · Derivative	112,797	$0.00	$0.00	Disclosure SEC source: 0001104659-25-003470 · tm253294-3_4seq1.xml · derivative · entry 3 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,797 Underlying: Common Stock · 112,797 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit ("PSU") converts into one share of the Issuer's common stock. F7 · derivative.exercise_date: On January 11, 2025, the Reporting Person was granted 112,797 PSUs. The PSUs shall vest upon the later of (A) the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2026 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter, and (B) the first commercial sale of YUTREPIA by the Issuer. F7 · derivative.expiration_date: On January 11, 2025, the Reporting Person was granted 112,797 PSUs. The PSUs shall vest upon the later of (A) the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2026 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter, and (B) the first commercial sale of YUTREPIA by the Issuer. Read SEC document
January 11, 2025 Filed Jan 14, 2025 21:37 UTC	Liquidia Corp LQDA · Entity 1860	GrantCommon Stock	112,797	$0.00	$0.00	Disclosure SEC source: 0001104659-25-003470 · tm253294-3_4seq1.xml · nonDerivative · entry 1 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 425,125 F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 25% of the RSUs shall vest on January 11, 2026 and the remaining RSUs shall vest ratably on a quarterly basis over three years thereafter. F3 · balance_after: Includes (i) 62,333 unvested RSUs of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 69,937 unvested RSUs of the 93,250 RSUs granted to the Reporting Person on January 11, 2024, (iii) 37,500 unvested RSUs of the 50,000 RSUs granted to the Reporting Person on January 15, 2024 and (iv) 9,044 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
December 02, 2024 Filed Dec 4, 2024 02:44 UTC	Liquidia Corp LQDA · Entity 1860	SaleCommon Stock	1,091	$11.51	$12,557.41	Disclosure SEC source: 0001104659-24-125248 · tm2430104-3_4seq1.xml · nonDerivative · entry 2 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 312,328 F4 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F5 · shares: These shares of common stock were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on January 16, 2022. F3 · balance_after: Includes (i) 70,125 unvested RSUs of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, none of which have vested as of the date of this Form 4 and (iii) 9,044 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
November 30, 2024 Filed Dec 4, 2024 02:44 UTC	Liquidia Corp LQDA · Entity 1860	Exercise / conversionRestricted Stock Unit · Derivative	2,343	$0.00	$0.00	Disclosure SEC source: 0001104659-24-125248 · tm2430104-3_4seq1.xml · derivative · entry 3 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,719 Underlying: Common Stock · 2,343 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. Read SEC document
November 30, 2024 Filed Dec 4, 2024 02:44 UTC	Liquidia Corp LQDA · Entity 1860	Exercise / conversionCommon Stock	2,343	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-24-125248 · tm2430104-3_4seq1.xml · nonDerivative · entry 1 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 313,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 16, 2022, the Reporting Person was granted 37,500 RSUs with 25% vesting on February 28, 2023 and the remaining RSUs vesting ratably on a quarterly basis over three years thereafter. Of those RSUs, a total of 25,781 have vested through November 30, 2024. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 70,125 unvested RSUs of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, none of which have vested as of the date of this Form 4 and (iii) 9,044 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
November 04, 2024 Filed Nov 6, 2024 19:08 UTC	HERON THERAPEUTICS, INC. /DE/ HRTX · Entity 7133	GrantStock Option (Right to Buy) · Derivative	227,272	$1.78 Strike: $1.78	$404,544.16	Disclosure SEC source: 0000950170-24-122084 · ownership.xml · derivative · entry 2 Kaseta Michael · CIK 0001724346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 227,272 Underlying: Common Stock · 227,272 shares Expires 2034-11-04 F3 · derivative.exercise_date: The stock options vest and become exercisable in 48 equal monthly installments beginning one month after the date of grant (11/4/2024). Read SEC document
November 04, 2024 Filed Nov 6, 2024 19:08 UTC	HERON THERAPEUTICS, INC. /DE/ HRTX · Entity 7133	GrantCommon Stock	37,879	Not disclosed	Not disclosed	Disclosure SEC source: 0000950170-24-122084 · ownership.xml · nonDerivative · entry 1 Kaseta Michael · CIK 0001724346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,879 F1 · security: The shares were granted as restricted stock units which vest in 16 equal quarterly installments beginning one quarter after the date of grant (11/4/2024). F2 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document
October 14, 2024 Filed Oct 16, 2024 00:08 UTC	Liquidia Corp LQDA · Entity 1860	SaleCommon Stock	3,892	$11.11	$43,231.17	Disclosure SEC source: 0001104659-24-108766 · tm2426238-3_4seq1.xml · nonDerivative · entry 1 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 311,076 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F2 · shares: These shares of common stock were sold to cover taxes associated with the settlement of restricted stock units ("RSUs") that were initially granted to the Reporting Person on January 11, 2023. F3 · balance_after: Includes (i) 70,125 unvested RSUs of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, none of which have vested as of the date of this Form 4 and (iii) 9,044 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
September 16, 2024 Filed Sep 18, 2024 21:53 UTC	ALIMERA SCIENCES INC ALIM · Entity 11664	Disposition to issuerStock Option (Right to Buy) · Derivative	1,825	Not disclosed Strike: $1.85	Not disclosed	Disclosure SEC source: 0001104659-24-101115 · tm2424353-5_4seq1.xml · derivative · entry 2 Kaseta Michael · CIK 0001724346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,825 shares Expires 2033-03-25 F1 · price: Pursuant to the terms of the Agreement and Plan of Merger, dated as of June 21, 2024 (the "Merger Agreement"), by and among the Issuer, ANI Pharmaceuticals, Inc., a Delaware corporation ("Parent") and ANIP Merger Sub INC., a Delaware corporation and a wholly owned indirect subsidiary of Parent, as of the effective time of the merger (the "Effective Time"), at the Effective Time, each stock option granted by the Issuer to purchase shares (each, an "Option") that was outstanding and unvested immediately prior to the Effective Time vested in full, and each Option that was outstanding and unexercised which had a per share exercise price that was less than ) $5.50 in cash, without interest (such amount, the "Closing Cash Consideration") was converted into the right to receive the sum of an amount in cash (without interest and subject to deduction for any required withholding as contemplated in the Merger Agreement) equal to: F2 · price: (A) the excess, if any, of the Closing Cash Consideration over the exercise price per share of such Option; multiplied by the number of shares underlying such Option and (B) one contingent value right ("CVR") representing the right to receive contingent cash payments subject to the achievement of certain milestones and the terms and conditions set forth in a contingent value rights agreement entered into between Parent and a rights agent. F1 · derivative.exercise_date: Pursuant to the terms of the Agreement and Plan of Merger, dated as of June 21, 2024 (the "Merger Agreement"), by and among the Issuer, ANI Pharmaceuticals, Inc., a Delaware corporation ("Parent") and ANIP Merger Sub INC., a Delaware corporation and a wholly owned indirect subsidiary of Parent, as of the effective time of the merger (the "Effective Time"), at the Effective Time, each stock option granted by the Issuer to purchase shares (each, an "Option") that was outstanding and unvested immediately prior to the Effective Time vested in full, and each Option that was outstanding and unexercised which had a per share exercise price that was less than ) $5.50 in cash, without interest (such amount, the "Closing Cash Consideration") was converted into the right to receive the sum of an amount in cash (without interest and subject to deduction for any required withholding as contemplated in the Merger Agreement) equal to: F2 · derivative.exercise_date: (A) the excess, if any, of the Closing Cash Consideration over the exercise price per share of such Option; multiplied by the number of shares underlying such Option and (B) one contingent value right ("CVR") representing the right to receive contingent cash payments subject to the achievement of certain milestones and the terms and conditions set forth in a contingent value rights agreement entered into between Parent and a rights agent. Read SEC document
September 16, 2024 Filed Sep 18, 2024 21:53 UTC	ALIMERA SCIENCES INC ALIM · Entity 11664	Disposition to issuerStock Option (Right to Buy) · Derivative	50,000	Not disclosed Strike: $2.99	Not disclosed	Disclosure SEC source: 0001104659-24-101115 · tm2424353-5_4seq1.xml · derivative · entry 1 Kaseta Michael · CIK 0001724346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2033-10-01 F1 · price: Pursuant to the terms of the Agreement and Plan of Merger, dated as of June 21, 2024 (the "Merger Agreement"), by and among the Issuer, ANI Pharmaceuticals, Inc., a Delaware corporation ("Parent") and ANIP Merger Sub INC., a Delaware corporation and a wholly owned indirect subsidiary of Parent, as of the effective time of the merger (the "Effective Time"), at the Effective Time, each stock option granted by the Issuer to purchase shares (each, an "Option") that was outstanding and unvested immediately prior to the Effective Time vested in full, and each Option that was outstanding and unexercised which had a per share exercise price that was less than ) $5.50 in cash, without interest (such amount, the "Closing Cash Consideration") was converted into the right to receive the sum of an amount in cash (without interest and subject to deduction for any required withholding as contemplated in the Merger Agreement) equal to: F2 · price: (A) the excess, if any, of the Closing Cash Consideration over the exercise price per share of such Option; multiplied by the number of shares underlying such Option and (B) one contingent value right ("CVR") representing the right to receive contingent cash payments subject to the achievement of certain milestones and the terms and conditions set forth in a contingent value rights agreement entered into between Parent and a rights agent. F1 · derivative.exercise_date: Pursuant to the terms of the Agreement and Plan of Merger, dated as of June 21, 2024 (the "Merger Agreement"), by and among the Issuer, ANI Pharmaceuticals, Inc., a Delaware corporation ("Parent") and ANIP Merger Sub INC., a Delaware corporation and a wholly owned indirect subsidiary of Parent, as of the effective time of the merger (the "Effective Time"), at the Effective Time, each stock option granted by the Issuer to purchase shares (each, an "Option") that was outstanding and unvested immediately prior to the Effective Time vested in full, and each Option that was outstanding and unexercised which had a per share exercise price that was less than ) $5.50 in cash, without interest (such amount, the "Closing Cash Consideration") was converted into the right to receive the sum of an amount in cash (without interest and subject to deduction for any required withholding as contemplated in the Merger Agreement) equal to: F2 · derivative.exercise_date: (A) the excess, if any, of the Closing Cash Consideration over the exercise price per share of such Option; multiplied by the number of shares underlying such Option and (B) one contingent value right ("CVR") representing the right to receive contingent cash payments subject to the achievement of certain milestones and the terms and conditions set forth in a contingent value rights agreement entered into between Parent and a rights agent. Read SEC document
September 03, 2024 Filed Sep 4, 2024 20:40 UTC	Liquidia Corp LQDA · Entity 1860	SaleCommon Stock	1,079	$9.50	$10,250.18	Disclosure SEC source: 0001104659-24-096915 · tm2423338-2_4seq1.xml · nonDerivative · entry 2 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 314,968 F4 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F5 · shares: These shares of common stock were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on January 16, 2022. F3 · balance_after: Includes (i) 77,917 unvested RSUs of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, none of which have vested as of the date of this Form 4 and (iii) 9,044 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
August 30, 2024 Filed Sep 4, 2024 20:40 UTC	Liquidia Corp LQDA · Entity 1860	Exercise / conversionRestricted Stock Unit · Derivative	2,344	$0.00	$0.00	Disclosure SEC source: 0001104659-24-096915 · tm2423338-2_4seq1.xml · derivative · entry 3 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,062 Underlying: Common Stock · 2,344 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. Read SEC document
August 30, 2024 Filed Sep 4, 2024 20:40 UTC	Liquidia Corp LQDA · Entity 1860	Exercise / conversionCommon Stock	2,344	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-24-096915 · tm2423338-2_4seq1.xml · nonDerivative · entry 1 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 316,047 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 16, 2022, the Reporting Person was granted 37,500 RSUs with 25% vesting on February 28, 2023 and the remaining RSUs vesting ratably on a quarterly basis over three years thereafter. Of those RSUs, a total of 23,438 have vested through August 30, 2024. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 77,917 unvested RSUs of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, none of which have vested as of the date of this Form 4 and (iii) 9,044 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
July 12, 2024 Filed Jul 15, 2024 22:23 UTC	Liquidia Corp LQDA · Entity 1860	SaleCommon Stock	3,906	$12.53	$48,942.18	Disclosure SEC source: 0001104659-24-079923 · tm2419492-1_4seq1.xml · nonDerivative · entry 1 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 312,389 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F2 · shares: These shares of common stock were sold to cover taxes associated with the settlement of restricted stock units ("RSUs") that were initially granted to the Reporting Person on January 11, 2023. F3 · balance_after: Includes (i) 77,917 unvested RSUs of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 93,250 and 50,000 unvested RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, none of which have vested as of the date of this Form 4 and (iii) 7,730 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
June 03, 2024 Filed Jun 5, 2024 01:26 UTC	Liquidia Corp LQDA · Entity 1860	SaleCommon Stock	1,094	$14.55	$15,917.70	Disclosure SEC source: 0001104659-24-068422 · tm2416451-4_4seq1.xml · nonDerivative · entry 2 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 316,295 F4 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F5 · shares: These shares of common stock were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on January 16, 2022. F3 · balance_after: Includes (i) 85,708 unvested RSUs of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 93,250 and 50,000 unvested RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, none of which have vested as of the date of this Form 4 and (iii) 7,730 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
May 31, 2024 Filed Jun 5, 2024 01:26 UTC	Liquidia Corp LQDA · Entity 1860	Exercise / conversionRestricted Stock Unit · Derivative	2,344	$0.00	$0.00	Disclosure SEC source: 0001104659-24-068422 · tm2416451-4_4seq1.xml · derivative · entry 3 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,406 Underlying: Common Stock · 2,344 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. Read SEC document
May 31, 2024 Filed Jun 5, 2024 01:26 UTC	Liquidia Corp LQDA · Entity 1860	Exercise / conversionCommon Stock	2,344	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-24-068422 · tm2416451-4_4seq1.xml · nonDerivative · entry 1 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 317,389 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 16, 2022, the Reporting Person was granted 37,500 RSUs with 25% vesting on February 28, 2023, with the remaining RSUs vesting ratably on a quarterly basis over three years thereafter. Of those RSUs, a total of 21,904 have vested through May 31, 2024. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 85,708 unvested RSUs of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 93,250 and 50,000 unvested RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, none of which have vested as of the date of this Form 4 and (iii) 7,730 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
April 12, 2024 Filed Apr 16, 2024 21:16 UTC	Liquidia Corp LQDA · Entity 1860	SaleCommon Stock	3,136	$14.58	$45,722.88	Disclosure SEC source: 0001104659-24-047887 · tm2411915-3_4seq1.xml · nonDerivative · entry 1 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 315,045 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F2 · shares: These shares of common stock were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on January 11, 2023. F3 · balance_after: Includes (i) 85,708 unvested RSUs of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 143,250 unvested RSUs granted to the Reporting Person on January 11, 2024, none of which have vested as of the date of this Form 4, and (iii) 7,730 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
March 18, 2024 Filed Mar 20, 2024 01:47 UTC	Liquidia Corp LQDA · Entity 1860	SaleCommon Stock	11,315	$15.82	$179,003.30	Disclosure SEC source: 0001104659-24-036347 · tm247887-4_4seq1.xml · nonDerivative · entry 3 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 318,181 F4 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F6 · shares: These shares of common stock were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on January 11, 2023. F3 · balance_after: Includes (i) 93,500 unvested RSUs of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 143,250 unvested RSUs granted to the Reporting Person on January 11, 2024, none of which have vested as of the date of this Form 4, and (iii) 7,730 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
March 18, 2024 Filed Mar 20, 2024 01:47 UTC	Liquidia Corp LQDA · Entity 1860	SaleCommon Stock	851	$15.82	$13,462.82	Disclosure SEC source: 0001104659-24-036347 · tm247887-4_4seq1.xml · nonDerivative · entry 2 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 329,496 F4 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F5 · shares: These shares of common stock were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on January 16, 2022. F3 · balance_after: Includes (i) 93,500 unvested RSUs of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 143,250 unvested RSUs granted to the Reporting Person on January 11, 2024, none of which have vested as of the date of this Form 4, and (iii) 7,730 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document
March 15, 2024 Filed Mar 20, 2024 01:47 UTC	Liquidia Corp LQDA · Entity 1860	Exercise / conversionRestricted Stock Unit · Derivative	2,344	$0.00	$0.00	Disclosure SEC source: 0001104659-24-036347 · tm247887-4_4seq1.xml · derivative · entry 4 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,750 Underlying: Common Stock · 2,344 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. Read SEC document
March 15, 2024 Filed Mar 20, 2024 01:47 UTC	Liquidia Corp LQDA · Entity 1860	Exercise / conversionCommon Stock	2,344	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-24-036347 · tm247887-4_4seq1.xml · nonDerivative · entry 1 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 330,347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 16, 2022, the Reporting Person was granted 37,500 RSUs with 25% vesting on February 28, 2023, with the remaining RSUs vesting ratably on a quarterly basis over three years thereafter. Of those RSUs, a total of 18,750 have vested through March 15, 2024. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 93,500 unvested RSUs of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 143,250 unvested RSUs granted to the Reporting Person on January 11, 2024, none of which have vested as of the date of this Form 4, and (iii) 7,730 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.